Found: 25
Select item for more details and to access through your institution.
Other causes of neurocognitive impairment than covert hepatic encephalopathy (CHE) are very frequent, either alone or associated with CHE, in cirrhotic patients with cognitive complaints.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 749, doi. 10.1111/apt.18148
- By:
- Publication type:
- Article
Editorial: Tracking the course of Wilson's disease.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: Quantity is important! Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: Tracking the course of Wilson's disease: Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 686, doi. 10.1111/apt.18194
- By:
- Publication type:
- Article
Editorial: The future of managing drug induced liver injury.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease. Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Review article: Oesophageal disorders in chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 715, doi. 10.1111/apt.18193
- By:
- Publication type:
- Article
Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Letter: Association of serum growth differentiation factor 15 and liver‐related outcomes in patients with MASLD—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Editorial: Quantity is important!
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: Decoding the enigma—Navigating complexity in MASLD management. Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Meta‐analysis: High pooled positive predictive value of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition no‐biopsy approach for coeliac disease testing in children.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 672, doi. 10.1111/apt.18177
- By:
- Publication type:
- Article
Clinical trial: The effectiveness of long‐acting somatostatin analogue for output reduction of high‐output intestinal fistula or small bowel enterostomy. A randomised controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 727, doi. 10.1111/apt.18166
- By:
- Publication type:
- Article
Review article: advances in the diagnosis and management of anorectal motility disorders.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 701, doi. 10.1111/apt.18170
- By:
- Publication type:
- Article
Editorial: Decoding the enigma—Navigating complexity in MASLD management.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 796, doi. 10.1111/apt.18165
- By:
- Publication type:
- Article
Clinical characteristics and HLA associations of azithromycin‐induced liver injury.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 787, doi. 10.1111/apt.18160
- By:
- Publication type:
- Article
Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Outcomes of patients with alcohol‐associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 778, doi. 10.1111/apt.18159
- By:
- Publication type:
- Article
Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 765, doi. 10.1111/apt.18154
- By:
- Publication type:
- Article
Letter: Association of serum growth differentiation factor 15 and liver‐related outcomes in patients with MASLD.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 737, doi. 10.1111/apt.18139
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 6, p. 669, doi. 10.1111/apt.17589
- Publication type:
- Article